Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Case Reports in Oncological Medicine|May 2, 2025
Successful Treatment of Innumerable Untreated Brain Metastases With Trastuzumab Deruxtecan in Chemotherapy-Naïve HER2-Mutated Non-Small-Cell Lung CancerSara Young, Sean C Dougherty, Angela M DeRidder, et al.Cancer|August 27, 2014
The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteriaRyan D Gentzler, Sarah E Yentz, Melissa L Johnson, et al.JTO Clinical and Research Reports|December 2, 2024
First Report of Response to Tarlatamab in a Patient With DLL3-Positive Pulmonary Carcinoid: Case ReportAlissa J Cooper, Natasha Rekhtman, Marina K Baine, et al.Current Oncology (Toronto, Ont.)|January 22, 2024
Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint InhibitorsPhilip Young, Omar Elghawy, Joseph Mock, et al.Journal of Hematology & Oncology|April 24, 2014
Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literatureJuehua Gao, Ryan D Gentzler, Andrew E Timms, et al.Cardio-Oncology (London, England)|September 28, 2020
Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case seriesPuja Arora, Laura Talamo, Patrick Dillon, et al.Frontiers in Oncology|October 10, 2022
Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapyFabian J Bolte, Sloane McTavish, Nathan Wakefield, et al.International Conference on Pervasive Computing Technologies for Healthcare : [Proceedings]. International Conference on Pervasive Computing Technologies for Healthcare|July 8, 2025
mHealth for Medication and Side Effect Monitoring: Patients' Attitudes Toward Smart Devices for Managing Oral Chemotherapy During Lung Cancer TreatmentAnna N Baglione, Sarah Tolman, Chloe Dapaah, et al.Clinical Lung Cancer|April 25, 2025
Real-World Outcomes of Tarlatamab in Small Cell Lung Cancer, Including Patients With Untreated Brain MetastasesFabian J Bolte, Sean C Dougherty, Abigail O Danos, et al.Frontiers in Oncology|February 12, 2026
Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosisSean C Dougherty, Rishika Singh, Caleb McKinney, et al.Pageof 5